A Case of NK / T - Cell Lymphoma Complicated by a Squamous Cell Carcinoma of Hard Palate during Combination Chemotherapy and Radiation Therapy

Hang Lak Lee(Hanyang University), Yong Wook Park(Hanyang University), Se Jin Jang(University of Ulsan), Il Young Choi(Hanyang University), Jung Hye Choi(Hanyang University Guri Hospital), In Soon Kim(Hanyang University), Woon Hyun Jun(Hanyang University), Young Yuel Lee(Hanyang University), Myung‐Ju Ahn(Sungkyunkwan University)
The Korean Journal of Internal Medicine
March 31, 2002
10.3904/kjim.2002.17.1.69
Cited by 1

Related Papers

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2019|3.4k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537